Research ExplorerPublicationsTissue-resident memory T cells in the kidney

Tissue-resident memory T cells in the kidney

Standard

Tissue-resident memory T cells in the kidney. / Asada, Nariaki; Ginsberg, Pauline; Gagliani, Nicola; Mittrücker, Hans-Willi; Panzer, Ulf.

In: SEMIN IMMUNOPATHOL, Vol. 44, No. 6, 11.2022, p. 801-811.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Asada, N, Ginsberg, P, Gagliani, N, Mittrücker, H-W & Panzer, U 2022, 'Tissue-resident memory T cells in the kidney', SEMIN IMMUNOPATHOL, vol. 44, no. 6, pp. 801-811. https://doi.org/10.1007/s00281-022-00927-7

APA

Asada, N., Ginsberg, P., Gagliani, N., Mittrücker, H-W., & Panzer, U. (2022). Tissue-resident memory T cells in the kidney. SEMIN IMMUNOPATHOL, 44(6), 801-811. https://doi.org/10.1007/s00281-022-00927-7

Vancouver

Asada N, Ginsberg P, Gagliani N, Mittrücker H-W, Panzer U. Tissue-resident memory T cells in the kidney. SEMIN IMMUNOPATHOL. 2022 Nov;44(6):801-811. https://doi.org/10.1007/s00281-022-00927-7

Bibtex

@article{e834d66b347d4ecf97f456e58cd3a75d,
title = "Tissue-resident memory T cells in the kidney",
abstract = "The identification of tissue-resident memory T cells (TRM cells) has significantly improved our understanding of immunity. In the last decade, studies have demonstrated that TRM cells are induced after an acute T-cell response, remain in peripheral organs for several years, and contribute to both an efficient host defense and autoimmune disease. TRM cells are found in the kidneys of healthy individuals and patients with various kidney diseases. A better understanding of these cells and their therapeutic targeting might provide new treatment options for infections, autoimmune diseases, graft rejection, and cancer. In this review, we address the definition, phenotype, and developmental mechanisms of TRM cells. Then, we further discuss the current understanding of TRM cells in kidney diseases, such as infection, autoimmune disease, cancer, and graft rejection after transplantation.",
keywords = "Humans, Immunologic Memory, Memory T Cells, Autoimmune Diseases, Neoplasms, Kidney, CD8-Positive T-Lymphocytes",
author = "Nariaki Asada and Pauline Ginsberg and Nicola Gagliani and Hans-Willi Mittr{\"u}cker and Ulf Panzer",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
month = nov,
doi = "10.1007/s00281-022-00927-7",
language = "English",
volume = "44",
pages = "801--811",
journal = "SEMIN IMMUNOPATHOL",
issn = "1863-2297",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Tissue-resident memory T cells in the kidney

AU - Asada, Nariaki

AU - Ginsberg, Pauline

AU - Gagliani, Nicola

AU - Mittrücker, Hans-Willi

AU - Panzer, Ulf

N1 - © 2022. The Author(s).

PY - 2022/11

Y1 - 2022/11

N2 - The identification of tissue-resident memory T cells (TRM cells) has significantly improved our understanding of immunity. In the last decade, studies have demonstrated that TRM cells are induced after an acute T-cell response, remain in peripheral organs for several years, and contribute to both an efficient host defense and autoimmune disease. TRM cells are found in the kidneys of healthy individuals and patients with various kidney diseases. A better understanding of these cells and their therapeutic targeting might provide new treatment options for infections, autoimmune diseases, graft rejection, and cancer. In this review, we address the definition, phenotype, and developmental mechanisms of TRM cells. Then, we further discuss the current understanding of TRM cells in kidney diseases, such as infection, autoimmune disease, cancer, and graft rejection after transplantation.

AB - The identification of tissue-resident memory T cells (TRM cells) has significantly improved our understanding of immunity. In the last decade, studies have demonstrated that TRM cells are induced after an acute T-cell response, remain in peripheral organs for several years, and contribute to both an efficient host defense and autoimmune disease. TRM cells are found in the kidneys of healthy individuals and patients with various kidney diseases. A better understanding of these cells and their therapeutic targeting might provide new treatment options for infections, autoimmune diseases, graft rejection, and cancer. In this review, we address the definition, phenotype, and developmental mechanisms of TRM cells. Then, we further discuss the current understanding of TRM cells in kidney diseases, such as infection, autoimmune disease, cancer, and graft rejection after transplantation.

KW - Humans

KW - Immunologic Memory

KW - Memory T Cells

KW - Autoimmune Diseases

KW - Neoplasms

KW - Kidney

KW - CD8-Positive T-Lymphocytes

U2 - 10.1007/s00281-022-00927-7

DO - 10.1007/s00281-022-00927-7

M3 - SCORING: Review article

C2 - 35411437

VL - 44

SP - 801

EP - 811

JO - SEMIN IMMUNOPATHOL

JF - SEMIN IMMUNOPATHOL

SN - 1863-2297

IS - 6

ER -